US Plans For End Of Covid-19 Shot, Treatment Coverage - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Pfizer (PFE) Ordered by FDA to Test Impact of Repeat Course of Paxlovid - BBG
August 19, 2022 3:48 PM EDTUS regulators ordered Pfizer (NYSE: PFE) to test the impact of an extra course of Paxlovid in people who experience a rebound in Covid-19 following treatment, Bloomberg reported Friday.
Bloomberg stated the drug will go through a further study after reports of the "mysterious phenomenon" continue to rise.... More
Moderna (MRNA), Pfizer (PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
August 18, 2022 12:03 PM EDTModerna (NASDAQ: MRNA), Pfizer (NYSE: PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
... More
